Phase I Study Of S-1, Irinotecan Plus Oxaliplatin Combination Therapy (S-Irox) For Unresectable Pancreatic Ductal AdenocarcinomaM. Sasaki,H. Ueno,S. Shiba, H. Hosoi, O. Akihiro,Y. Sakamoto,S. Kondo,C. Morizane,T. OkusakaANNALS OF ONCOLOGY（2016）引用 3|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
